MedPath
TGA Approval

UZEDY risperidone 125 mg/0.35 mL modified release suspension for injection pre-filled syringe (412313)

412313

UZEDY risperidone 125 mg/0.35 mL modified release suspension for injection pre-filled syringe

Teva Pharma Australia Pty Ltd

February 18, 2025

Medicine

Medicine

Active

Registered

Active Ingredients

risperidone

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

UZEDY risperidone 125 mg/0.35 mL modified release suspension for injection pre-filled syringe (412313) - TGA 批准文号 | MedPath